Industry Voices and Cannabis News | Page 100 of 143 | Cannabiz

‘Significant’ probe underway as Epsilon creditors raise ‘various matters’

by Steve Jones January 31, 2024July 11, 2024

Administrators probing the boardroom battles and stricken finances of Epsilon Healthcare have told shareholders that “significant […]

LGP reports sales downturn but predicts a ‘re-rating’ of Australian firms amid US rescheduling report

by Steve Jones January 31, 2024July 11, 2024

Shareholders reject remuneration report as Althea is dealt ‘first strike’

by Steve Jones January 31, 2024July 11, 2024

Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix

by Steve Jones and Martin Lane January 31, 2024July 11, 2024

Administrator ponders offers for Bod assets ahead of report to creditors

by Steve Jones January 30, 2024July 16, 2024

‘We have to do something, we can’t just sit on our hands’

by Steve Jones January 30, 2024July 16, 2024

Coming up trumps: how Australian patients are reaping the rewards of a $50 bet

by Steve Jones January 24, 2024July 16, 2024

Hunt for Medlab buyer drew ‘bottom feeders’, says MD as plan unfolds to deliver shareholder return

by Steve Jones January 17, 2024July 11, 2024

SAS-B deep dive: more women turn to flower and anxiety on the rise as cannabis sands continue to shift

by Steve Jones January 17, 2024July 11, 2024

ODC spells out cannabis vape import reforms and flags further TGO 93 review

by Steve Jones January 17, 2024July 11, 2024